{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:56:01Z","timestamp":1792788961099,"version":"4.5.0"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2016,3,7]],"date-time":"2016-03-07T00:00:00Z","timestamp":1457308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0150721","type":"journal-article","created":{"date-parts":[[2016,3,7]],"date-time":"2016-03-07T13:34:32Z","timestamp":1457357672000},"page":"e0150721","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":48,"title":["Predicted Strain Coverage of a New Meningococcal Multicomponent Vaccine (4CMenB) in Spain: Analysis of the Differences with Other European Countries"],"prefix":"10.1371","volume":"11","author":[{"given":"Raquel","family":"Abad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Stella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Boccadifuoco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Comanducci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Bambini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Muzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio A.","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,3,7]]},"reference":[{"issue":"6","key":"ref1","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1086\/315158","article-title":"The changing epidemiology of meningococcal disease in the United States, 1992\u20131996","volume":"180","author":"NE Rosenstein","year":"1999","journal-title":"J Infect Dis"},{"issue":"18","key":"ref2","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200105033441807","article-title":"Meningococcal disease","volume":"344","author":"NE Rosenstein","year":"2001","journal-title":"N Engl J Med"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1128\/CMR.13.1.144-166.2000","article-title":"Update on meningococcal disease with emphasis on pathogenesis and clinical management","volume":"13","author":"M van Deuren","year":"2000","journal-title":"Clin Microbiol Rev"},{"issue":"9580","key":"ref4","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1016\/S0140-6736(07)61016-2","article-title":"Epidemic meningitis, meningococcemia, and <italic>Neisseria meningitidis<\/italic>","volume":"369","author":"DS Stephens","year":"2007","journal-title":"Lancet"},{"key":"ref5","unstructured":"Centers for Disease Control and Prevention. 2012. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, <italic>Neisseria meningitidis<\/italic>, 2010. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.cdc.gov\/abcs\/reports-findings\/survreports\/mening10.pdf\" xlink:type=\"simple\">http:\/\/www.cdc.gov\/abcs\/reports-findings\/survreports\/mening10.pdf<\/ext-link>."},{"key":"ref6","article-title":"Surveillance of invasive bacterial diseases in Europe, 2011","year":"2013"},{"key":"ref7","unstructured":"Garrido M, Magui\u00f1a M, Cano R. Enfermedad meningoc\u00f3cica en Espa\u00f1a. An\u00e1lisis de la temporada 2012\u20132013. Red Nacional de Vigilancia Epidemiol\u00f3gica. Centro Nacional de Epidemiolog\u00eda. Julio 2014. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.isciii.es\/ISCIII\/es\/contenidos\/fd-servicios-cientifico-tecnicos\/fd-vigilancias-alertas\/fd-enfermedades\/MNG_informe_2012-2013_confirmados.pdf\" xlink:type=\"simple\">http:\/\/www.isciii.es\/ISCIII\/es\/contenidos\/fd-servicios-cientifico-tecnicos\/fd-vigilancias-alertas\/fd-enfermedades\/MNG_informe_2012-2013_confirmados.pdf<\/ext-link>"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1016\/j.vaccine.2013.07.083","article-title":"Effectiveness of meningococcal serogroup C vaccine programmes","volume":"21","author":"R Borrow","year":"2013","journal-title":"Vaccine"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.4049\/jimmunol.138.12.4402","article-title":"An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues","volume":"138","author":"J Finne","year":"1987","journal-title":"J Immunol"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1086\/648966","article-title":"Review of meningococcal group B vaccines","volume":"50","author":"DM Granoff","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/0140-6736(91)91961-S","article-title":"Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway","volume":"338","author":"G Bjune","year":"1991","journal-title":"Lancet"},{"key":"ref12","first-page":"195","article-title":"Vaccine against group B <italic>Neisseria meningitidis<\/italic>: protection trial and mass vaccination results in Cuba","volume":"14","author":"GV Sierra","year":"1991","journal-title":"NIPH Ann"},{"issue":"8827","key":"ref13","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/0140-6736(92)93086-3","article-title":"Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil","volume":"340","author":"JC de Moraes","year":"1992","journal-title":"Lancet"},{"issue":"9","key":"ref14","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0264-410X(94)00037-N","article-title":"Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile","volume":"13","author":"J Boslego","year":"1995","journal-title":"Vaccine"},{"issue":"16","key":"ref15","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/jama.281.16.1520","article-title":"Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile","volume":"281","author":"JW Tappero","year":"1999","journal-title":"JAMA"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/ije\/dyn228","article-title":"Use of an observational cohort study to estimate the effectiveness of the New Zealand group B meningococcal vaccine in children aged under 5 years","volume":"38","author":"Y Galloway","year":"2009","journal-title":"Int J Epidemiol"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1473-3099(11)70027-5","article-title":"From tailor-made to ready-to-wear meningococcal B vaccines: longitudinal study of a clonal meningococcal B outbreak","volume":"11","author":"F Caron","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S1473-3099(09)70324-X","article-title":"Serogroup B meningococcal vaccines: an unfinished story","volume":"10","author":"M Sadarangani","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"Suppl. 2","key":"ref19","doi-asserted-by":"crossref","first-page":"B87","DOI":"10.1016\/j.vaccine.2012.01.033","article-title":"The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens","volume":"30","author":"D Serruto","year":"2012","journal-title":"Vaccine"},{"key":"ref20","unstructured":"FDA News Release. FDA approves a second vaccine to prevent serogroup B meningococcal disease; 2015. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm431370.htm\" xlink:type=\"simple\">http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm431370.htm<\/ext-link>."},{"issue":"45","key":"ref21","doi-asserted-by":"crossref","first-page":"19490","DOI":"10.1073\/pnas.1013758107","article-title":"Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines","volume":"107","author":"J Donnelly","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1473-3099(13)70006-9","article-title":"Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment","volume":"13","author":"U Vogel","year":"2013","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"ref23","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1073\/pnas.95.6.3140","article-title":"Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms","volume":"95","author":"MC Maiden","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"ref24","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1099\/jmm.0.05517-0","article-title":"Antigenic and\/or phase variation of PorA protein in non-subtypable <italic>Neisseria meningitidis<\/italic> strains isolated in Spain","volume":"53","author":"B Alcal\u00e1","year":"2004","journal-title":"J Med Microbiol"},{"issue":"7","key":"ref25","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1099\/mic.0.26131-0","article-title":"Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component","volume":"149","author":"EA Thompson","year":"2003","journal-title":"Microbiology"},{"issue":"6","key":"ref26","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1128\/CVI.00027-10","article-title":"Characterization of <italic>fHbp<\/italic>, <italic>nhba<\/italic> (gna2132), <italic>nadA<\/italic>, <italic>porA<\/italic>, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccine","volume":"17","author":"J Lucidarme","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"10","key":"ref27","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1128\/CVI.00202-12","article-title":"Interlaboratory standardization of the sandwich enzyme-linked immunosorbent assay designed for MATS, a rapid, reproducible method for estimating the strain coverage of investigational vaccines","volume":"19","author":"BD Plikaytis","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"43","key":"ref28","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1016\/j.vaccine.2013.08.006","article-title":"Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage","volume":"31","author":"G Frosi","year":"2013","journal-title":"Vaccine"},{"issue":"4","key":"ref29","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1128\/CVI.00669-14","article-title":"A large portion of meningococcal antigen typing system-negative meningococcal strains from Spain is killed by Sera from adolescents and infants immunized with 4CMenB","volume":"22","author":"R Abad","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1471-2180-14-111","article-title":"Diversity of Greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine","volume":"14","author":"G Tzanakaki","year":"2014","journal-title":"BMC Microbiol"},{"issue":"2","key":"ref31","first-page":"103","article-title":"Predicted strain coverage of a new protein-based meningococcal vaccine in the Czech Republic","volume":"63","author":"P K\u0159\u00ed\u017eov\u00e1","year":"2014","journal-title":"Epidemiol Mikrobiol Imunol"},{"issue":"10","key":"ref32","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/INF.0b013e31829aa63b","article-title":"A multi-country evaluation of <italic>Neisseria meningitidis<\/italic> serogroup B factor H-binding proteins and implications for vaccine coverage in different age groups","volume":"32","author":"SK Hoiseth","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.vaccine.2013.03.063","article-title":"Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB)","volume":"32","author":"JA Bettinger","year":"2013","journal-title":"Vaccine"},{"key":"ref34","unstructured":"Tozer SJ, Whiley DM, Smith HV, Rockett R, Jennison A, Doyle C, et al. The use of the Meningococcal Antigen Typing System (MATS) to assess Australian epidemiology and meningococcal strain coverage with multicomponent serogroup B vaccine. Poster presented at 27<sup>th<\/sup> ICP, August 24\u201329 (2013)."},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1128\/IAI.01085-12","article-title":"Transcriptional regulation of the <italic>nadA<\/italic> gene in <italic>Neisseria meningitidis<\/italic> impacts the prediction of coverage of a multicomponent meningococcal serogroup B vaccine","volume":"81","author":"L Fagnocchi","year":"2013","journal-title":"Infect Immun"},{"issue":"7","key":"ref36","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1128\/CVI.00825-13","article-title":"Neisseria adhesin A variation and revised nomenclature scheme","volume":"21","author":"S Bambini","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"ref37","unstructured":"Abad R, Enr\u00edquez R, Medina V, V\u00e1zquez JA. Changes in the clonal lineages of serogroup B invasive meningococcal population in Spain (2008\u20132010). Poster presented (P083) at 11<sup>th<\/sup> EMGM Meeting. 2011."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0150721","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:32:42Z","timestamp":1692232362000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0150721"}},"subtitle":[],"editor":[{"given":"Riccardo","family":"Manganelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,3,7]]},"references-count":37,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0150721","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,7]]}}}